Epigenetics Archives | EMBL
EMBL scientists investigate rare lung disease
Researchers in EMBL’s Zaugg group have studied the causes of pulmonary arterial hypertension (PAH), a rare disease that causes high blood pressure in the arteries of the lungs. The study, carried out in collaboration with Stanford University School of Medicine, compared lung cells of patients with the disease with those of healthy individuals. Instead of finding a single clear cause, their results showed large epigenetic disturbances.
How females shut off their second X chromosome
Scientists provide important new insights into the molecular basis of X-inactivation
Understanding molecular mechanisms of ageing
Understanding how ageing works at a molecular level
Wielding the genetic scissors
What CRISPR may bring for the future of biology, and how it is used at EMBL
Transcription factors controlled by DNA sequence
EMBL scientists gain mechanistic insights into how cellular signalling controls gene regulation
The scientific origins of Edith Heard
EMBL’s next Director General reflects on the questions that drive her research
PhD goals: why not start a company?
EMBL-EBI PhD student launches start-up focusing on epigenetics and wellbeing
Chromatin usage reveals developmental trajectories
EMBL scientists show how chromatin usage in individual cells reveals developmental trajectories
Welcome: Matthieu Boulard
New EMBL group leader investigates the mystery of heritable gene silencing
Edith Heard awarded Grand Prix Inserm 2017
EMBL Director General elect, Edith Heard, awarded 2017’s Grand Prix Inserm for her work in epigenetics
